Indivior (LON:INDV) Stock Crosses Below Two Hundred Day Moving Average – What’s Next?

Indivior PLC (LON:INDVGet Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 811.18 ($10.44) and traded as low as GBX 733.50 ($9.44). Indivior shares last traded at GBX 746 ($9.60), with a volume of 9,229,962 shares traded.

Analysts Set New Price Targets

Separately, Jefferies Financial Group reissued a “buy” rating and set a GBX 1,800 ($23.17) target price on shares of Indivior in a research report on Tuesday, December 17th.

Get Our Latest Analysis on INDV

Indivior Trading Up 0.2 %

The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The company has a market capitalization of £1.17 billion, a price-to-earnings ratio of -618.54, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The business has a fifty day moving average price of GBX 812.35 and a 200 day moving average price of GBX 811.18.

About Indivior

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Read More

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.